Drug details

Otezla (apremilast tablets)

type of DMARDs, PDE4 Inhibitors

Otezla (apremilast) is a phosphodiesterase 4 (PDE4) inhibitor used to treat adult patients with active psoriatic arthritis.

The drug is often used to treat Psoriatic arthritis .

This drug may have the following side effects:

• diarrhea,
• nausea
• headache,
• ,
• upper respiratory tract infection, and
• tension headache

The following drugs are related to Otezla, either as a replacement or used together:

• Humira (adalimumab injection solution for subcutaneous administration)
• Yusimry (adalimumab-aqvh injection)
• Imraldi (adalimumab-xxxx injection, for subcutaneous use)
• Adbry (tralokinumab-ldrm for injection)
• Hyrimoz (alimumab-adaz injection)
• Zithranol Cream (anthralin microcrystalline encapsulated cream)
• Azulfidine EN-Tabs (sulfasalazine delayed release tablets)
• Bryhali (halobetasol propionate lotion)
• Celebrex (celecoxib)
• Olux (clobetasol propionate)
• Olux-E (clobetasol propionate foam)
• Sotyktu (deucravacitinib tablets)
• Voltaren (diclofenac sodium)
• Voltaren XR (diclofenac sodium extended-release tablets)
• Voltaren Gel (diclofenac sodium gel)
• Duobrii (halobetasol propionate and tazarotene lotion)
• Enbrel (etanercept)
• MiCort HC (hydrocortisone acetate cream)
• Inflectra (infliximab-dyyb intravenous injection)
• Remicade (infliximab)
• Kimyrsa (oritavancin for injeciton)
• Purinethol (mercaptopurine)
• Trexall (methotrexate)
• Xatmep (methotrexate oral solution)
• Skyrizi (risankizumab-rzaa injection)
• Spevigo (spesolimab-sbzo injection)
• Vtama (tapinarof cream)
• Tofidence (tocilizumab-bavi injection)